Analysis of nearly 8,000 adults found 45% keep the weight off after one year As the use of injectable GLP-1 drugs continues to rise, questions persist about what happens after patients stop taking them in real-world settings
The researchers assessed the change in body weight from baseline within each trial and subgroup and they also carried out a mediation analysis to differentiate between direct and indirect effects of semaglutide on weight loss, the latter of which was mediated by nausea or vomiting
Treatment may not be suitable for: Pregnancy or breastfeeding Certain medical conditions (assessed during consultation) Current chemotherapy treatment Severe kidney or liver disease How Often Should I Get Treatments
A., Samlan, G., Lohani, M., Thangavel, N., & Al-Kasim, M
Peptide selection, dosing, and study design decisions should be made in consultation with experienced researchers familiar with the specific experimental model being used
Retatrutide is not something people should attempt to obtain or use without medical oversight